BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30025109)

  • 1. Stem Cell Treatment for Age-Related Macular Degeneration: the Challenges.
    Singh MS; MacLaren RE
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD78-AMD82. PubMed ID: 30025109
    [No Abstract]   [Full Text] [Related]  

  • 2. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retinal cell therapy using iPS cells].
    Takahashi M
    Rinsho Shinkeigaku; 2013; 53(11):1016. PubMed ID: 24291864
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-Based Therapy for Degenerative Retinal Disease.
    Zarbin M
    Trends Mol Med; 2016 Feb; 22(2):115-134. PubMed ID: 26791247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human stem cell-derived retinal cells for macular diseases.
    Atala A
    Lancet; 2015 Feb; 385(9967):487-8. PubMed ID: 25458727
    [No Abstract]   [Full Text] [Related]  

  • 6. Stem cells in retinal regeneration: past, present and future.
    Ramsden CM; Powner MB; Carr AJ; Smart MJ; da Cruz L; Coffey PJ
    Development; 2013 Jun; 140(12):2576-85. PubMed ID: 23715550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.
    Schwartz SD; Regillo CD; Lam BL; Eliott D; Rosenfeld PJ; Gregori NZ; Hubschman JP; Davis JL; Heilwell G; Spirn M; Maguire J; Gay R; Bateman J; Ostrick RM; Morris D; Vincent M; Anglade E; Del Priore LV; Lanza R
    Lancet; 2015 Feb; 385(9967):509-16. PubMed ID: 25458728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.
    Mandai M; Watanabe A; Kurimoto Y; Hirami Y; Morinaga C; Daimon T; Fujihara M; Akimaru H; Sakai N; Shibata Y; Terada M; Nomiya Y; Tanishima S; Nakamura M; Kamao H; Sugita S; Onishi A; Ito T; Fujita K; Kawamata S; Go MJ; Shinohara C; Hata KI; Sawada M; Yamamoto M; Ohta S; Ohara Y; Yoshida K; Kuwahara J; Kitano Y; Amano N; Umekage M; Kitaoka F; Tanaka A; Okada C; Takasu N; Ogawa S; Yamanaka S; Takahashi M
    N Engl J Med; 2017 Mar; 376(11):1038-1046. PubMed ID: 28296613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients.
    Song WK; Park KM; Kim HJ; Lee JH; Choi J; Chong SY; Shim SH; Del Priore LV; Lanza R
    Stem Cell Reports; 2015 May; 4(5):860-72. PubMed ID: 25937371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's old is new again: Autologous stem cell transplant for AMD.
    Byrne LC
    Sci Transl Med; 2017 Apr; 9(387):. PubMed ID: 28446683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of novel therapies using human iPS cell-derived retinal pigment epithelia].
    Arakawa D; Ito A; Osakada F
    Nihon Yakurigaku Zasshi; 2016; 148(4):217. PubMed ID: 27725570
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Age-Related Macular Degeneration with Pluripotent Stem Cell-Derived Retinal Pigment Epithelium.
    Vitillo L; Tovell VE; Coffey P
    Curr Eye Res; 2020 Mar; 45(3):361-371. PubMed ID: 31777296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration.
    Melville H; Carpiniello M; Hollis K; Staffaroni A; Golestaneh N
    J Transl Med; 2013 Mar; 11():53. PubMed ID: 23452406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene and Induced Pluripotent Stem Cell Therapy for Retinal Diseases.
    Maeda A; Mandai M; Takahashi M
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():201-216. PubMed ID: 31018110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryonic stem cell implantation for the treatment of Stargardt’s disease and macular degeneration.
    Regen Med; 2011 Sep; 6(5):539-40. PubMed ID: 21916588
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preclinical Study of Human Induced Pluripotent Stem Cell-derived Retinal Pigment Epithelium Cell Sheets Transplantation].
    Kamao H
    Nippon Ganka Gakkai Zasshi; 2016 Nov; 120(11):754-63. PubMed ID: 30074740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Implants for Age-Related Macular Degeneration.
    Abbasi J
    JAMA; 2018 Jun; 319(22):2263. PubMed ID: 29896614
    [No Abstract]   [Full Text] [Related]  

  • 18. Stem cells in age-related macular degeneration and Stargardt's macular dystrophy.
    Sunness JS
    Lancet; 2015 Jul; 386(9988):29. PubMed ID: 26169864
    [No Abstract]   [Full Text] [Related]  

  • 19. Stem cells in age-related macular degeneration and Stargardt's macular dystrophy.
    Zhang GY; Liao T; Fu XB; Li QF
    Lancet; 2015 Jul; 386(9988):29-30. PubMed ID: 26169863
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration.
    Lu B; Malcuit C; Wang S; Girman S; Francis P; Lemieux L; Lanza R; Lund R
    Stem Cells; 2009 Sep; 27(9):2126-35. PubMed ID: 19521979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.